4. INTRODUCTION
Diabetic ketoacidosis (DKA) is among the most serious acute complications of T2DM.
It has a high mortality rate if unrecognized. The overall mortality is <1%, but a
mortality rate of>5% in the elderly has been reported.
Mortality in patients with DKA is frequently related to the underlying aetiological
precipitant rather than the metabolic sequelae of hyperglycemia or ketoacidosis.
DKA is mainly characterized by hyperglycemia, acidosis-producing derangements, and
dehydration.
Infection, disruption of insulin, and the onset of diabetes are some of the common
causes of DKA.
KKM Clinical Practice Guide MANAGEMENT OF TYPE 2 DIABETES MELLITUS (2020)
5. PATHOPHYSIOLOGY
Insulin Deficiency
Breakdown of fat
& amino acid
Osmotic diuresis
causes
dehydration &
Electrolyte
disturbance
Acid buildup
(Ketones)
LIVER
SHOCK
KETONE
INSULIN
BLOOD
Blood becomes acidic
(Metabolic Acidosis)
BRAIN
It can cause acute
cerebral edema
(1%)
8. HISTORY/MEDICINE
-Type 2 Diabetes
• Tab Metformin 500mg BD
• S/C Mixtard 30 unit BD
• Defaulted insulin injection & follow-up for 1/12
-Dyslipidemia
-Hypertension
-No other past history of medical/surgical
-No known food or drug allergies
9. Generalized Body Weakness x 2/7
Palpitation
Fever
Right Breast Swelling
COMPLAINT
YOURLOGO
10. EXAMINATION
RESPONSE
• Alert & Conscious, GCS 15/15
AIRWAYS
• Open, patent & maintainable, Not tachypneic
BREATHING
• RR: 19/min
• Lungs: Equal air entry & clear
• The breast appears to be swelling but no visible pus
CIRCULATION
• Skin pink, not mottled, mild dehydrated looking
• CVS: Dual Rhythm No Murmur
• Pulse: Tachycardia, regular, strong, warm
• Abdomen: Soft, no tender & guarding
• No pedal edema
16. X-RAY (CHEST)
Finding
• AP View
• No abnormalities
• No consolidation
visible
• No cardiomegaly
• No
pneumothorax
• Gastric bubble
seen
• X-Ray Clear
17. ADDITIONAL TEST
Serum
Osmolality
Formula : (2 x serum
[Na]) + [glucose] + [urea]
(all in mmol/L)
Or laboratory measured value
(2 x [124]) + [19.3] + [7.4] =
274.7
Normal range 275-295 mosmol/kg
Anion Gap
Formula
([Na+] + [K+]) − ([Cl-] + [HCO −])
(124 + 4.8) – (95 + 10.5) =
23.3
Normal range 8 – 16 mmol/L
21. o Restoration of patient’s hydration (Normal
Saline/Hartman)
o Insulin administration
o Constant monitoring of Vital Signs & DXT (hourly)
o Constant urine output monitoring
o Keep patient NBM with the administration of
Pantoprazole/Nexium
o Repeat investigation per management to Ensure
clinical & biochemical parameters are continuing to
improve or are normal
o Prevent hypokalemia by KCL administration with fluid
given
BASIC PRINCIPAL
22. MANAGEMENT GIVEN @ ED
Reassure patient
Let the patient rest in bed comfortably
IV Access (Large Bore) x2
Constant V/Sign & Cardiac Monitoring
ECG & Portable CXR
IVD N/Saline bolus over 1 H
Tab PCM 1g
S/C Actrapid 6 unit
IV Pantoprazole 40mg
CBD inserted
23. Start DKA Regime:
1. -IVD N/Saline 1L over 1 Hour (Post Mx DXT:19.0 mmol/L)
2. -IVD N/Saline 1L over 2 Hour (Post Mx DXT: 18.5 mmol/L)
3. -IVD N/Saline 1L over 4 Hour
IVI Actrapid 50 unit in 50ml N/Saline run 6ml/H
Check DXT hourly
IVD N/Saline 500ml with KCL 1g maintenance
Refer medical team for further management
IV Cefuroxime 1.5g stat
Admit to HDU
24. PRECAUTION
IF DXT < 13.5, START ON NSD5% MAINTENANCE
IF K < 3, FOR FAST CORRECT
IF K 3-3.4,+1.5GKCL IN EACH PINT OF DRIP
IF K 3.5-4.0,+1G KCL IN EACG PINT OF DRIP
25. AIM OF TREATMENT
1. Rate of fall Of Ketone is at 0.5mmol/L/Hr
2. HCO3 rise at 3 mmol/L/Hr
3. Blood glucose falls 3 mmol/L/Hr
4. Maintain serum potassium at a normal range
5. Ensure clinical and biochemical parameters improving
6. Continue IV fluid replacement/maintenance
7. Avoid hypoglycemic
8. Assess for complications of treatment (eg: Fluid Overload, Hypoglycemia, Cerebral
Edema)
9. Treat precipitating factors if necessary